These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31313390)

  • 21. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
    Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE
    Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
    Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
    BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.
    Bavry AA; Khaliq A; Gong Y; Handberg EM; Cooper-Dehoff RM; Pepine CJ
    Am J Med; 2011 Jul; 124(7):614-20. PubMed ID: 21596367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
    Kjeldsen SE; Hedner T; Syvertsen JO; Lund-Johansen P; Hansson L; Lanke J; Lindholm LH; De Faire U; Dahlöf B; Karlberg BE;
    J Hypertens; 2002 Jun; 20(6):1231-7. PubMed ID: 12023696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive medication exposure and cardiovascular outcomes in hemodialysis patients.
    Shireman TI; Phadnis MA; Wetmore JB; Zhou X; Rigler SK; Spertus JA; Ellerbeck EF; Mahnken JD
    Am J Nephrol; 2014; 40(2):113-22. PubMed ID: 25139551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal of antihypertensive drugs in older people.
    Reeve E; Jordan V; Thompson W; Sawan M; Todd A; Gammie TM; Hopper I; Hilmer SN; Gnjidic D
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012572. PubMed ID: 32519776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
    Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving role of β-adrenergic receptor blockers in managing hypertension.
    Poirier L; Lacourcière Y
    Can J Cardiol; 2012 May; 28(3):334-40. PubMed ID: 22595449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
    Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
    Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular outcomes of β-blocker-calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real-world retrospective study.
    Lin J; Guo Q; Lu Z; Chai D; Peng F; Lin J
    J Clin Hypertens (Greenwich); 2023 May; 25(5):440-452. PubMed ID: 37120711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension.
    Tsujimoto T; Kajio H
    J Am Heart Assoc; 2020 Dec; 9(23):e018827. PubMed ID: 33222584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.
    Shireman TI; Mahnken JD; Phadnis MA; Ellerbeck EF
    BMC Cardiovasc Disord; 2016 Mar; 16():60. PubMed ID: 27012911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score-matched cohort study.
    Nakafero G; Grainge MJ; Valdes AM; Townsend N; D Mallen C; Zhang W; Doherty M; Mamas M; Abhishek A
    Rheumatology (Oxford); 2021 Dec; 60(12):5686-5696. PubMed ID: 33710319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive treatment after stroke and all-cause mortality--an analysis of the General Practitioner Research Database (GPRD).
    Toschke AM; Wolfe CD; Heuschmann PU; Rudd AG; Gulliford M
    Cerebrovasc Dis; 2009; 28(2):105-11. PubMed ID: 19506368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
    Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
    J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.
    Bangalore S; Sawhney S; Messerli FH
    J Am Coll Cardiol; 2008 Oct; 52(18):1482-9. PubMed ID: 19017516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.